Financials
- Market Capitalization 4.22 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-41.64
Fiyat/satışlar oranı
8.9
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1472 | TNGX Tango Therapeutics, Inc. - Common Stock | 25.28 USD | -0.75% | +5.55% | -5.74% | +269.05% | 4.26 B USD | ||
| 1475 | RLAY Relay Therapeutics, Inc. - Common Stock | 19.42 USD | -0.21% | -2.51% | +4.97% | +422.04% | 4.26 B USD | ||
| 1503 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 37.18 USD | +0.27% | -6.42% | +90.67% | +293.44% | 4.14 B USD | ||
| 1511 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 41.77 USD | +0.46% | +6.18% | +15.67% | +28.21% | 4.03 B USD |